Request Deal Involvement

AbbVie completed the acquisition of Syndesi Therapeutics from Novo Holdings for $1bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cleary Gottlieb Steen & Hamilton

legal advisors

Cleary Gottlieb Steen & Hamilton

Goodwin Procter

legal advisors

Goodwin Procter

Lazard

financial advisors

Lazard

Deloitte

legal advisors

Deloitte

or

Principals

ABBVIE INC

bidder

ABBVIE INC

SYNDESI THERAPEUTICS

target

SYNDESI THERAPEUTICS

NOVO HOLDINGS A/S

vendor

NOVO HOLDINGS A/S

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - AbbVie completed the acquisition of Syndesi Therapeutics from Novo Holdings for $1bn.